Fingerpaint, an independent, full-service, nationwide marketing agency, closed on the previously announced purchase of its office space at 395 Broadway in downtown Saratoga Springs, NY, from Myron M. Hunt Inc.

Fresh off its $7 billion acquisition of San Diego-based Impact Biomedicines and its JAK inhibitor program targeting myelofibrosis, Celgene is planning to open a biopharma incubator on its corporate campus in New Jersey.

Vetter Pharma – a Germany-based contract company specializing in aseptic filling and packaging of drugs into syringes, vials and cartridges – broke ground on its U.S. headquarters in Des Plaines, Illinois.

Barely a week after announcing it was moving into a new corporate headquarters, Sangamo Therapeutics announced that the company has dosed the first patient in its Phase I/II gene therapy trial.

Less than one month after announcing plans for construction of a South Carolina manufacturing facility, surgical solutions firm Arthrex announced the company’s plans for the expansion of its global headquarters in Florida.

Beleaguered PixarBio Corporation slashed the company’s workforce by half and moved its operations from Massachusetts to New Hampshire. PixarBio revealed its moves in a July 2017 filing with the U.S. Securities and Exchange Commission.